In vitro susceptibility testing procedures for fosfomycin tromethamine.
AUTOR(ES)
Barry, A L
RESUMO
Fosfomycin tromethamine (previously fosfomycin trometamol) is an orally administered fosfomycin which may be used for single-dose therapy of uncomplicated urinary tract infections. Fosfomycin tromethamine, norfloxacin, and trimethoprim-sulfamethoxazole inhibited greater than 90% of 352 bacterial isolates representing 25 different species; trimethoprim and nalidixic acid had narrower spectrums of activity. Strains of Escherichia, Citrobacter, Enterobacter, and Klebsiella species were much more susceptible when glucose-6-phosphate was added to the test medium, but isolates belonging to other genera were not affected.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=284319Documentos Relacionados
- Comparative pharmacokinetics of tromethamine fosfomycin and calcium fosfomycin in young and elderly adults.
- In vitro chloramphenicol susceptibility testing of Haemophilus influenzae: disk diffusion procedures and assays for chloramphenicol acetyltransferase.
- In Vitro Chloramphenicol Susceptibility Testing of Haemophilus influenzae: Disk Diffusion Procedures and Assays for Chloramphenicol Acetyltransferase
- Inhalation challenge with specific grass pollen antigens in asthmatics and the effect of lodoxamide tromethamine.
- In Vitro Susceptibility Testing with Tobramycin